Immunotherapy Buzz | GenomeWeb

Immunotherapy Buzz

Immunotherapies are enabling some cancer patients to live beyond the time they were told they had left, the New York Times' Denise Grady writes. She cautions, though, that treatments don't work for everyone and can have side effects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.